IGC PHARMA, INC.
Asset & Liabilities Breakdown
FY2025
FY2024
FY2023
FY2022
FY2021
FY2020
FY2019
FY2018
FY2017
FY2016
FY2015
FY2014
FY2013
FY2012
FY2011
Asset Breakdown FY2015
Total Assets: $20.3M
Liabilities Breakdown FY2015
Total Liabilities: $5.6M
Asset Breakdown
Total Assets: $20.3M
| Line Item | Value | % of Total |
|---|---|---|
| Cash & Equivalents | $824.5K | 4.1% |
| Accounts Receivable | $993.3K | 4.9% |
| Inventory | $709.6K | 3.5% |
| Property, Plant & Equipment | $7.8M | 38.3% |
| Goodwill | $982.8K | 4.8% |
| Intangible Assets | $306.1K | 1.5% |
| Other Assets | $8.7M | 42.9% |
Liabilities Breakdown
Total Liabilities: $5.6M
| Line Item | Value | % of Total |
|---|---|---|
| Accounts Payable | $174.6K | 3.1% |
| Long-Term Debt | $323.9K | 5.8% |
| Other Liabilities | $5.1M | 91.1% |